In our data, it was up-regulated in ccRCC and predicted to target SFRP1, a known regulator of the Wnt signaling pathway and a tumor suppressor gene whose loss has been observed in a majority of RCC patients [75]. Here, SFRP1 is linked to nonpapillary renal cell carcinoma.